Many side effects peak during dose escalation and improve as the body adjusts
Healthcare professionals often weigh these factors and make individualized recommendations based on the patients overall health
Effect of a treatment strategy of tight control for rheumatoid arthritis (the TICORA study): a single-blind randomised controlled trial
The study followed approximately 800 patients for up to 72 weeks, documenting significant improvements in liver health among those receiving semaglutide treatment
Clinical sequelae include CVD, metabolic disorders, and neurocognitive disorders as dysbiosis is associated with inflammaging, the chronic low-grade inflammation that accelerates atherosclerosis, insulin resistance and cognitive decline
Here are the main safety concerns: Dosing errors: The FDA has reported multiple dosing errors with compounded semaglutide, particularly when its dispensed in multi-dose vials